￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What factors affect survival in the treatment of ALK-positive NSCLC with brigatinib?

2026-02-01 22:25:32

Check Details
What are the indications for erdafitinib and what kind of drug is it?

2026-02-01 22:25:32

Check Details
What is erdafitinib and how does it work?

2026-02-01 22:25:32

Check Details
What are the functions and efficacy of erdafitinib?

2026-02-01 22:25:32

Check Details
What is the dosage of bedaquiline?

2026-02-01 22:25:32

Check Details
Bedaquiline is a targeted drug to accurately combat multi-drug-resistant tuberculosis

2026-02-01 22:25:32

Check Details
Can bedaquiline kill bacteria in half a year?

2026-02-01 22:25:32

Check Details
How long does it take to take bedaquiline to turn negative?

2026-02-01 22:25:32

Check Details
Bedaquiline: New hope for multidrug-resistant tuberculosis treatment

2026-02-01 22:25:32

Check Details
Hazards after discontinuation of sotoracib (AMG510)

2026-02-01 22:25:32

Check Details
Which version of Sotoracib (AMG510) works best

2026-02-01 22:25:32

Check Details
Does Sotolaxib (AMG510) have a big impact on vision?

2026-02-01 22:25:32

Check Details
Category
相关知识